| 前收盘价格 | 24.48 |
| 收盘价格 | 24.67 |
| 成交量 | 1,506,348 |
| 平均成交量 (3个月) | 999,955 |
| 市值 | 1,264,705,152 |
| 价格/销量 (P/S) | 4.21 |
| 股市价格/股市净资产 (P/B) | 4.91 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2024 |
| 营业毛利率 | -45.90% |
| 营业利益率 (TTM) | -12.66% |
| 稀释每股收益 (EPS TTM) | -2.69 |
| 季度收入增长率 (YOY) | 23.40% |
| 总债务/股东权益 (D/E MRQ) | 10.97% |
| 流动比率 (MRQ) | 4.10 |
| 营业现金流 (OCF TTM) | 7.78 M |
| 杠杆自由现金流 (LFCF TTM) | 19.38 M |
| 资产报酬率 (ROA TTM) | -7.50% |
| 股东权益报酬率 (ROE TTM) | -43.02% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | CareDx, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.50 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.45% |
| 机构持股比例 | 96.05% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 35.00 (BTIG, 45.96%) | 购买 |
| 35.00 (Goldman Sachs, 45.96%) | 购买 | |
| 中 | 35.00 (45.96%) | |
| 平均值 | 35.00 (45.96%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 24.54 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 05 Nov 2024 | 35.00 (45.95%) | 购买 | 22.90 |
| Goldman Sachs | 16 Oct 2024 | 35.00 (45.95%) | 购买 | 26.18 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合